Neurodegenerative & DemyelinatingApril 15, 20264 min read

One-page cheat sheet: Progressive supranuclear palsy

Quick-hit shareable content for Progressive supranuclear palsy. Include visual/mnemonic device + one-liner explanation. System: Neurology.

Progressive supranuclear palsy (PSP) is one of those neurodegenerative diagnoses that shows up on exams as a “pattern recognition” vignette: an older adult with early falls, vertical gaze palsy, and a stiff, axial, upright posture that doesn’t fit classic Parkinson disease (PD). If you can spot that triad fast, you’ll snag easy points.


PSP in one line (memorize this)

Progressive supranuclear palsy = a tauopathy causing early postural instability with falls + vertical (especially downward) gaze palsy + axial rigidity with poor levodopa response.


Visual / mnemonic device (quick-hit)

“PSP = Penguin Staring Problem”

Picture a tall, stiff penguin standing upright, falling backward, and staring straight ahead because it can’t look down.

  • Penguin postureaxial rigidity, extended neck, upright stance
  • Falling backwardearly postural instability, early falls
  • Staring / can’t look downvertical gaze palsy (classically downward)

The high-yield core: how PSP presents

Key clinical features

  • Early falls (often backward) due to postural instability
  • Vertical supranuclear gaze palsy
    • Impaired voluntary vertical eye movements (often downgaze first)
    • Reflex eye movements may be relatively preserved early (think “supranuclear”)
  • Axial rigidity > limb rigidity
  • Pseudobulbar features: dysarthria, dysphagia, emotional lability
  • Cognitive/behavioral changes (frontal executive dysfunction)

What makes it not typical Parkinson disease

  • Poor or minimal response to levodopa
  • Early gait/postural instability rather than late
  • Prominent eye movement abnormalities (vertical gaze palsy is a giant clue)
  • Tremor is usually less prominent than in PD

“Supranuclear” eye findings (exam-friendly)

Supranuclear palsy means the problem is above the ocular motor nuclei, so:

  • Voluntary vertical gaze is impaired early
  • Vestibulo-ocular reflex (VOR) can be relatively preserved early (you can sometimes elicit eye movement with head rotation when the patient can’t do it on command)

USMLE-style phrasing:

  • “Difficulty looking down to read or descend stairs”
  • “Frequent falls when walking, especially backward”
  • “Staring, reduced blinking, masked facies”

Pathology: what PSP is made of

Etiology / pathology

  • Sporadic neurodegenerative disorder
  • Tauopathy: abnormal hyperphosphorylated tau accumulation in neurons and glia
  • Classically involves:
    • Midbrain (key for vertical gaze control)
    • Basal ganglia and brainstem circuits for posture/gait

Gross imaging clue (Step 2-level pattern recognition)

  • MRI may show midbrain atrophy with preserved pons → “hummingbird sign” (aka “penguin sign” in some descriptions)

Quick comparison table: PSP vs Parkinson disease vs MSA

FeaturePSPParkinson diseaseMSA (Multiple system atrophy)
FallsEarly, often backwardLaterEarly-ish possible
Eye movementsVertical gaze palsy (downgaze)Usually normal earlyNo classic vertical palsy
RigidityAxial > limbsLimbs often prominentVariable
Autonomic failureNot the main featureCan occur laterProminent early (orthostasis, urinary)
Levodopa responsePoorGood (esp early)Poor/limited
PathologyTauα\alpha-synuclein (Lewy bodies)α\alpha-synuclein (glial cytoplasmic inclusions)
MRI clueMidbrain atrophy (“hummingbird”)Often nonspecific“Hot cross bun” (pons) can be seen

Classic vignette (what the question stem will look like)

An older adult with:

  • Frequent falls within the first year or two of symptoms
  • Stiff, upright posture and gait instability
  • Difficulty looking down (trouble reading, going down stairs)
  • Parkinsonism that does not improve with levodopa

Diagnosis: Progressive supranuclear palsy


Management (what USMLE expects you to know)

  • No disease-modifying therapy
  • Symptomatic and supportive:
    • Trial of levodopa may be attempted but usually minimal benefit
    • PT/OT, gait training, fall prevention
    • Speech/swallow evaluation (aspiration risk)
    • Address mood/cognition and caregiver support

High-yield prognosis note: progressive course with increasing falls, dysphagia, aspiration risk.


Rapid-fire “don’t miss” facts

  • PSP is a tauopathy, not a synucleinopathy.
  • Vertical gaze palsy (especially downward) is the single most testable distinguishing feature.
  • Think PSP when you see early falls + axial rigidity + poor levodopa response.
  • MRI clue: midbrain atrophy“hummingbird sign.”